Founded in 1984, Fine Foods & Pharmaceuticals N.T.M. S.p.A. is an Italian independent Contract Development & Manufacturing Organisation (CDMO). It develops and manufactures contract products for the pharmaceutical, nutraceutical and cosmetics industries. It is the first Italian CDMO listed on Euronext STAR Milan. In 2021 it became a Benefit Corporation, strengthening its ethical and transparent business model.
Group revenue for 2023 was € 251.8 million and showed an increase of 21.7% compared to 2022. Adjusted EBITDA showed an increase of 64.2% in 2023 compared to the previous year.
The 2023 Sustainability Report showed a year of significant achievements. The company has strengthened its commitment to sustainability as defined in its 2025 strategy, aligning with the UN’s Sustainable Development Goals – Agenda 2030. This led to substantial advancements and the attainment of targets, enhancing the company’s ESG performance.
Prestigious awards were received, including the “Platinum” EcoVadis rating obtained in August 2022 and confirmed in August 2023 with a score of 83 and which placed Fine Foods in the top one per cent of the 100,000 companies evaluated by the agency. Additionally, Morningstar-Sustainalytics rated Fine Foods’ ability to manage ESG risks as “Strong” in its annual rating.
“We are proud of our exceptional performance in 2023, with revenue growth nearly twice the usual levels. The robustness of our business model and organisation has allowed a rebound in margins, and we are on the cusp of exceeding historical benchmarks. As the market expands, we are prepared to increase our market share: the investments to increase production capacity already completed within the Cosmetic BU, and those planned for the Pharma and Food BUs in the next two years, will enable us to meet the growing customer interest in our Group. This results in a highly favourable outlook for the 2024-2028 period.” – Fine Foods & Pharmaceuticals N.T.M. S.p.A. CEO Giorgio Ferraris.
For 40 years, Fine Foods has been establishing genuine, transparent and results-oriented relationships with its customers and is considered a reliable partner. To demonstrate its approach, Fine Foods will attend Vitafoods in Geneva again this year, the main nutraceutical industry event in Europe. The event is a platform to unveil the newest products and services and engage in dialogue on sectoral challenges, supported by an extensive schedule of events over three days.
Our reliability is rooted in a commitment to excellence and quality across all functions and stages, along with a focus on ESG issues which are increasingly integrated into different Fine Foods business processes. This includes the Research and Development department’s dedication to suggesting solutions aimed at decreasing the environmental impact of products.
The Group has chosen to be certified for its carbon footprint under UNI EN ISO 14064 standards in 2023. This underscores its commitment to transparent environmental reporting and establishing footprint reduction goals following expert recommendations. Fine Foods supported customers in calculating the carbon footprint of their products and looked for strategies to make them more sustainable. Fine Foods is selecting and testing new materials for the circular economy.
The Group’s strategy included the increasingly active and responsible involvement of players along the supply chain. It expanded the number of suppliers engaged in the process of assessing and improving their environmental and social performance, with a focus on respect for human rights.
The company’s focus on people’s health continues, by participating in local programmes and adopting good health practices (cancer prevention, physical activity, healthy diet and psychological well-being).
The Group intends to continue its sustainability programme and serve as a benchmark for assessing products that align with the evolving market demands.
